Cortavance

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

hydrocortisone aceponate

Available from:

Virbac New Zealand Limited

INN (International Name):

hydrocortisone aceponate

Composition:

hydrocortisone aceponate 0.58 g/litre

Therapeutic area:

Anti-inflammatory

Authorization status:

ACVM Registered

Authorization date:

2008-05-30

Summary of Product characteristics

Bottle Label – Front November 2019
[Virbac Logo]
FOR ANIMAL TREATMENT ONLY
KEEP OUT OF REACH OF CHILDREN
DERMATOLOGY
RESTRICED VETERINARY MEDICINE
Cortavance

Glucocorticoid cutaneous spray with minimal systemic effect
ACTIVE CONSTITUENT:
0.584 mg/mL Hydrocortisone aceponate
For topical use on Dogs for the symptomatic relief of inflammatory and
pruritic dermatosis.
Net contents 76 mL (or 31 ml)
Bottle Label – Back November
2019
READ ENTIRE PACKAGE INSERT BEFORE USING THIS PRODUCT
DOSAGE AND ADMINISTRATION:
The recommended dose is 1.52 g/cm² of hydrocortisone aceponate
once daily. This
dosage can be achieved with two pump spray activations over a surface
to be treated
equivalent to a 10 cm x 10 cm square. Repeat the treatment daily for 7
consecutive days.
In cases of conditions requiring an extended treatment, the
responsible veterinarian
should subject the use of the product to the risk-benefit assessment.
Refer to package
insert for full use details.
STORAGE:
Store in a well-ventilated place at or below 25ºC. Keep container
tightly closed.
 Registered Trade Mark of Virbac
ACVM No. A10060
Registered to and distributed by
Virbac New Zealand limited
26 – 30 Maui St,
Pukete, Hamilton
[B]:
EXP:
Flammable liquid and vapour. May be
harmful if swallowed. Causes eye
irritation.
Carton Text – Front November 2019
[Virbac Logo]
FOR ANIMAL TREATMENT ONLY
KEEP OUT OF REACH OF CHILDREN
DERMATOLOGY
RESTRICED VETERINARY MEDICINE
Cortavance

Glucocorticoid cutaneous spray with minimal systemic effect
ACTIVE CONSTITUENT:
0.584 mg/mL Hydrocortisone aceponate
For topical use on Dogs for the symptomatic relief of inflammatory and
pruritic dermatosis.
Net contents 76 mL (or 31 mL)
Carton Text – Back November
2019
READ ENTIRE PACKAGE INSERT BEFORE USING THIS PRODUCT
DOSAGE AND ADMINISTRATION:
Topical administration to the skin. The product should be applied by
activating the spray
pump spray from 10 cm above the affected area. The recommended dose is
1.52 g/cm²
of hydrocortisone aceponate once daily. This do